Search results
Results From The WOW.Com Content Network
Duration of overall response The duration of overall response is measured from the time measurement criteria are met for CR or PR (whichever status is recorded first) until the first date that recurrence or PD is objectively documented, taking as reference for PD the smallest measurements recorded since the treatment started.
The immune-related response criteria, first published in 2009, [1] arose out of observations that immuno-oncology drugs would fail in clinical trials that measured responses using the WHO or RECIST Criteria, because these criteria could not account for the time gap in many patients between initial treatment and the apparent action of the immune ...
It is a component of the University of Texas Health Science Center, San Antonio which is located adjacently. The center serves more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin , San Antonio , Laredo and the Rio Grande Valley , and handles more than 120,000 patient visits each year, and has a ...
PET response criteria in solid tumors (PERCIST) is a set of rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment, using positron emission tomography (PET). The criteria were published in May 2009 in the Journal of Nuclear Medicine (JNM). [1]
The University of Texas Health Science Center at San Antonio (UTHSCSA, pronounced "U-tesk-uh"), [2] doing business as UT Health San Antonio, is a public academic health science center in San Antonio, Texas. It is part of the University of Texas System. UT Health San Antonio is the largest health sciences university in South Texas.
A 2024 systematic review of the literature found that chemoradiation with 5-FU and mitomycin C, as used in the Nigro Protocol, improves outcomes like colostomy-free survival in anal cancer patients compared to alternatives like cisplatin. However, it can lead to more severe side effects, especially blood-related toxicity. [7]
Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology, PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically. Similarly ...
STMC is located about 10 miles northwest of Downtown San Antonio.. In 2009, 27,884 persons were directly employed at the center, and the combined budget of all entities at the South Texas Medical Center totaled $3.3 billion. [2]